ArticleBMC infectious diseases2025
HEV seroprevalence and associated risk factors among HIV-positive individuals in post-earthquake Kathmandu: a 2016 cross-sectional study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years).BMC infectious diseases · 2026Article
- Seroprevalence and determinants of hepatitis E virus infection among people living with HIV in Chiang Mai, Thailand: a cross-sectional analysis.Scientific reports · 2026Article
- Serological and molecular characterization of hepatitis E virus and co-infections during the 2014 Biratnagar outbreak in Nepal.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatitis E virus (HEV) infection poses a significant public health challenge, particularly in immunocompromised populations such as those living with HIV. Limited data exist on HEV seroprevalence and its correlates among HIV-positive individuals in urban low-resource settings, especially in the aftermath of disasters. This study investigates HEV seroprevalence and risk factors among HIV positive individuals in 2016, a post-earthquake period in Kathmandu, Nepal, with relevance to ongoing challenges in 2025.
methodsWe conducted a cross-sectional serological study among 200 HIV-positive individuals from Sukraraj Tropical and Infectious Disease Hospital's (STIDH) Antiretroviral Therapy (ART) center in Kathmandu. Serological testing determined anti-HEV IgG and IgM status using Wantai Hepatitis E (HEV-IgG/M) ELISA kits. Sociodemographic, behavioral, and clinical data were collected via structured interviews and medical records. Multivariable logistic regression identified independent predictors of anti-HEV IgG seropositivity. Statistical analyses used Chi-square, Mann-Whitney U, and Cochran's Q tests, with p < 0.05 considered significant. A comparative general population sample (n = 100) from earthquake-affected districts was also analyzed.
resultsOverall, 43.5% (87/200) of HIV-positive participants tested positive for anti-HEV IgG. Key demographic predictors included increasing age, which showed a significant non-linear association (adjusted OR = 3.95 for age, 0.60 for age²; p < 0.001), and a marginal association with male gender (aOR = 2.03; p = 0.059). In contrast, no significant associations were observed between HEV seropositivity and specific drinking water sources, water processing methods, eating habits, smoking status, CD4 count, HIV viral load suppression, common comorbidities, or routine liver and hematological markers. anti-HEV IgG seroprevalence was considerably higher than that of Hepatitis B virus (4.5%) and Hepatitis C virus (5.0%) in the cohort and notably absent in a comparative general population sample. The predictive model showed good performance (AUC = 0.80), supporting its exploratory utility.
conclusionOur findings reveal a high burden of past HEV exposure among HIV-positive individuals in post-earthquake Kathmandu, with age being a key correlate. The absence of HEV IgG positivity in the general population sample suggests that HEV exposure during this period may have been localized to vulnerable clinical groups. The lack of association with traditional behavioral or clinical markers highlights the complexity of transmission in this setting. These results underscore the need to integrate HEV awareness and targeted screening into HIV care in endemic regions. Future studies should prioritize longitudinal follow-up, genotype surveillance, and environmental sampling to inform public health preparedness and response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.